Regional cooperation in south asia biotech

Introduction

Regional cooperation in biotechnology refers to collaboration among South Asian countries in scientific research, technology development, public health, agriculture, environmental protection and the regulation of biological resources. Countries such as India, Bangladesh, Nepal, Bhutan, Pakistan, Sri Lanka, Maldives and Afghanistan face several common challenges, including infectious diseases, food insecurity, climate change, biodiversity loss and inadequate healthcare infrastructure. Biotechnology can help address these challenges through vaccines, diagnostic technologies, improved crops, biofertilisers and environmental solutions.

Regional cooperation is particularly important because biological risks and environmental problems do not remain confined within national borders. Cooperation can promote scientific progress while ensuring ethical research, biosafety, equitable benefit-sharing and protection of traditional knowledge.

Legal and institutional framework

The South Asian Association for Regional Cooperation (SAARC), established in 1985, provides an institutional platform for regional collaboration. Its objectives include improving the quality of life, promoting economic development and strengthening collective self-reliance. Although SAARC does not have a comprehensive biotechnology regulatory system, its framework supports cooperation in public health, agriculture, scientific research and environmental protection.

The SAARC Framework Agreement for Energy Cooperation and other regional initiatives demonstrate the possibility of developing common mechanisms in specialised sectors. Biotechnology cooperation can similarly be promoted through research networks, scientific exchanges and coordinated disease surveillance.

Other relevant international instruments include:

Convention on Biological Diversity, 1992: Provides principles for biodiversity conservation, sustainable use and fair benefit-sharing.

Cartagena Protocol on Biosafety, 2000: Establishes international rules concerning the safe transfer, handling and use of living modified organisms.

Nagoya Protocol, 2010: Provides a framework for access to genetic resources and fair and equitable sharing of benefits.

TRIPS Agreement, 1994: Establishes minimum standards for intellectual property protection, including biotechnology-related inventions.

These instruments provide common legal principles, although their implementation differs among South Asian countries.

Areas of regional biotechnology cooperation

1. Public health and disease control

South Asian countries face common public health challenges, including tuberculosis, dengue, malaria and emerging infectious diseases. Regional cooperation can strengthen vaccine research, laboratory networks, genomic surveillance and the exchange of diagnostic technologies.

Joint research programmes can also improve preparedness for future pandemics. Countries may share epidemiological information, laboratory expertise and medical resources while maintaining appropriate privacy and biosafety safeguards.

2. Agricultural biotechnology

Agriculture remains an important economic sector across South Asia. Biotechnology can support the development of drought-resistant crops, disease-resistant varieties, improved seeds and biological pest-control methods.

Regional research institutions can exchange germplasm, scientific knowledge and agricultural technologies. However, such cooperation must respect national seed laws, farmers' rights, intellectual property rights and biosafety requirements.

3. Biodiversity and genetic resources

South Asia possesses significant biological diversity, including medicinal plants, microorganisms and valuable genetic resources. Regional cooperation can help prevent biopiracy and encourage the conservation of shared ecosystems.

The Nagoya Protocol promotes fair benefit-sharing when genetic resources are accessed and utilised. Countries should establish transparent access procedures and ensure that local and indigenous communities receive appropriate benefits.

4. Biosafety and ethical regulation

Different regulatory standards may create difficulties when biotechnology products, biological samples and genetically modified organisms move across borders. Regional cooperation can encourage common safety principles, transparent risk assessment and scientific information-sharing.

However, harmonisation should not eliminate national regulatory authority. Each country must retain the power to impose appropriate safeguards according to its domestic laws.

Important case laws

1. Divya Pharmacy v. Union of India (2018)

The Uttarakhand High Court examined the relationship between access to biological resources and benefit-sharing under the Biological Diversity Act, 2002. The judgment recognised the importance of benefit-sharing obligations in relation to commercial utilisation of biological resources.

Its significance for regional cooperation lies in demonstrating that countries must develop effective systems to ensure that biological resources are used lawfully and that benefits are shared fairly.

2. Novartis AG v. Union of India (2013)

In this landmark judgment, the Supreme Court interpreted Section 3(d) of the Patents Act, 1970, concerning patentability of pharmaceutical inventions. The Court rejected the patent claim because the applicant failed to establish the required enhanced therapeutic efficacy.

The judgment is relevant to South Asian biotechnology cooperation because it highlights the importance of balancing pharmaceutical innovation, public health and access to affordable medicines.

3. Research Foundation for Science, Technology and Natural Resource Policy v. Union of India (2005)

The Supreme Court considered environmental protection issues relating to hazardous waste and emphasised the importance of scientific assessment and regulatory supervision.

The decision is relevant to regional biotechnology governance because cross-border movement of hazardous biological materials requires effective environmental safeguards and cooperation among regulatory authorities.

4. Indian Council for Enviro-Legal Action v. Union of India (1996)

The Supreme Court reinforced the application of the polluter-pays principle and the responsibility of industries causing environmental damage.

This principle is relevant to biotechnology industries operating across South Asia because environmental harm caused by unsafe biological manufacturing or waste disposal must be addressed through effective accountability mechanisms.

Challenges in regional cooperation

Regional biotechnology cooperation faces several difficulties:

Differences in national biotechnology laws and regulatory institutions.

Unequal research funding and technological capabilities.

Intellectual property disputes and disagreements over genetic resources.

Political tensions affecting scientific collaboration.

Concerns regarding biosafety, biosecurity and cross-border transfer of biological materials.

Limited infrastructure for joint research and disease surveillance.

These challenges require stronger institutional coordination and transparent legal arrangements.

Measures for strengthening cooperation

South Asian countries should establish regional biotechnology research networks, promote joint vaccine and agricultural research, and develop common biosafety guidelines. They should also encourage academic exchanges, technology transfer and training programmes.

A regional framework could establish procedures for sharing biological samples, protecting confidential research information, recognising ethical approvals and distributing benefits arising from jointly developed technologies.

Conclusion

Regional cooperation in South Asian biotechnology is essential for addressing shared health, agricultural and environmental challenges. SAARC and international biodiversity and biosafety instruments provide a foundation for such collaboration. Judicial decisions concerning biological resources, patents and environmental protection also demonstrate the importance of responsible scientific development. Stronger cooperation, equitable benefit-sharing and harmonised safety standards can help South Asian countries achieve sustainable biotechnology development while protecting public interests.